Clinical Trials
8 trialsNCT06885697 2026-06-05
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT05104736 2026-05-12
PT-112 in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT05918302 2026-05-12
LEVEL
Grupo Espanol de Tumores Neuroendocrinos
Phase 3 Recruiting
NCT01851395 2026-05-05
Rapid Autopsy and Procurement of Cancer Tissue
National Institutes of Health Clinical Center (CC)
Terminated
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT04417660 2026-04-07
Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT06189183 2026-04-01
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Active not recruiting
NCT04234113 2026-03-27
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Phase 1 Terminated